Natco Pharma Ltd - Stock Price

As on23 Sep 2021
  • NSE : NATCOPHARM
  • BSE : 524816
  • ISIN CODE : INE987B01026
  • Industry : Pharmaceuticals & Drugs
  • House : Natco
Natco Pharma Ltd is not traded on BSE/NSE
NSE
884.40
-1.07 %-9.55
BSE
883.15
-1.22 %-10.95

Ratios

Parameter MAR 21  MAR 20  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)24.1625.32-4.58
   CEPS(Rs)30.6530.65-0.02
   DPS(Rs)5.256.75-22.22
   Book NAV/Share(Rs)224.88206.049.14
   Tax Rate(%)23.6719.4521.72
Margin Ratios
   Core EBITDA Margin(%)29.0928.312.76
   EBIT Margin(%)28.4528.68-0.79
   Pre Tax Margin(%)27.8127.630.65
   PAT Margin (%)21.2322.26-4.62
   Cash Profit Margin (%)26.8427.11-0.99
Performance Ratios
   ROA(%)9.4310.30-8.46
   ROE(%)11.2712.71-11.37
   ROCE(%)13.9914.82-5.63
   Asset Turnover(x)0.440.46-4.02
   Sales/Fixed Asset(x)0.861.07-19.78
   Working Capital/Sales(x)1.151.25-8.33
Efficiency Ratios
   Fixed Capital/Sales(x)1.160.9324.66
   Receivable days84.4493.77-9.95
   Inventory Days118.7796.3823.22
   Payable days50.7565.96-23.07
Valuation Parameters
   PER(x)34.1619.9970.85
   PCE(x)26.9216.5163.06
   Price/Book(x)3.672.4649.37
   Yield(%)0.641.33-52.29
   EV/Net Sales(x)7.334.9448.37
   EV/Core EBITDA(x)21.1913.7154.55
   EV/EBIT(x)25.3716.0358.26
   EV/CE(x)3.142.0652.22
   M Cap / Sales7.344.8152.55
Growth Ratio
   Net Sales Growth(%)7.16-8.57183.54
   Core EBITDA Growth(%)2.87-25.41111.30
   EBIT Growth(%)0.46-30.07101.52
   PAT Growth(%)-3.43-28.6988.05
   EPS Growth(%)-4.58-28.3083.81
Financial Stability Ratios
   Total Debt/Equity(x)0.070.08-22.57
   Current Ratio(x)4.453.3931.04
   Quick Ratio(x)3.022.6314.85
   Interest Cover(x)44.5827.4562.39
   Total Debt/Mcap(x)0.020.03-48.12

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 883.15. Its current market capitalisation stands at Rs 16103.17 Cr. In the latest quarter, company has reported Gross Sales of Rs. 16854 Cr and Total Income of Rs.17546 Cr. The company's management includes M Adinarayana, Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News

close